Home Biosimilar Antibodies Cytoskeletal Signaling Integrin antibody Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) For research use only.
Not for use in humans.

Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)

Synonyms:

Erlizumab (anti-Integrin b2 / ITGB2 / CD18) is a humanized monoclonal antibody targeted against Integrin beta-2 and used as a therapy for hemorrhagic shock. MW: 146.66 kD.

Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)

Purity & Quality Control

≥99

Choose Selective Integrin Inhibitors

Biological Activity

Description Erlizumab (anti-Integrin b2 / ITGB2 / CD18) is a humanized monoclonal antibody targeted against Integrin beta-2 and used as a therapy for hemorrhagic shock. MW: 146.66 kD.

Product Details

CAS No. 211323-03-4
Molecular Weight 146.66
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) | Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) supplier | purchase Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) | Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) cost | Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) manufacturer | order Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) | Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) distributor